What is Jefferies's price target for ENTA?

Jefferies's latest stated price target for Enanta Pharmaceuticals Inc. (ENTA) is $20, from its action on Oct 1, 2025.

What is Jefferies's rating on ENTA?

Jefferies rates ENTA Buy, a bullish rating, as of Oct 1, 2025.

When did Jefferies last change its view on ENTA?

On Oct 1, 2025, Jefferies upgrades to Buy from Hold, price target $20.

Jefferies ENTA price target and rating history

Enanta Pharmaceuticals Inc. (ENTA) · Health Care

Jefferies rates Enanta Pharmaceuticals Inc. (ENTA) Buy with a $20 price target, as of its latest action on Oct 1, 2025. It has published 3 rating actions on ENTA since October 2021, including 1 upgrade and 1 downgrade.

Current rating: Buy
Price target: $20
Median target, all firms: Too few
Actions on ENTA: 3

Jefferies price target on ENTA

Jefferies price target on ENTA, each point a stated target, October 2021 to October 2025. Targets before August 2023 (divided by 2) are adjusted for a stock split, going by the prior target Jefferies restated.

Every Jefferies rating on ENTA

Oct 1, 2025
UpgradeJefferies upgrades to Buy from Hold, price target $20
Aug 8, 2023
DowngradeJefferies downgrades to Hold from Buy, price target $49 to $18
Oct 7, 2021
InitiateJefferies starts coverage at Buy, price target $95

Questions about Jefferies and ENTA

What is Jefferies's price target for ENTA?: Jefferies's latest stated price target for Enanta Pharmaceuticals Inc. (ENTA) is $20, from its action on Oct 1, 2025.
What is Jefferies's rating on ENTA?: Jefferies rates ENTA Buy, a bullish rating, as of Oct 1, 2025.
When did Jefferies last change its view on ENTA?: On Oct 1, 2025, Jefferies upgrades to Buy from Hold, price target $20.

More ENTA rating histories

All Jefferies ratings ENTA news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.